The estimated Net Worth of Neal J Curran is at least $72.3 Thousand dollars as of 27 August 2003. Neal Curran owns over 4,500 units of Invacare stock worth over $4,290 and over the last 21 years Neal sold IVC stock worth over $67,999.
Neal has made over 3 trades of the Invacare stock since 2003, according to the Form 4 filled with the SEC. Most recently Neal sold 1,366 units of IVC stock worth $67,999 on 19 November 2004.
The largest trade Neal's ever made was exercising 4,500 units of Invacare stock on 27 August 2003 worth over $106,605. On average, Neal trades about 1,973 units every 90 days since 2003. As of 27 August 2003 Neal still owns at least 6,500 units of Invacare stock.
You can see the complete history of Neal Curran stock trades at the bottom of the page.
Neal's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44036.
Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon, and Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: